QNRX
Quoin·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Stock Price Surged Significantly
MACD Death Cross
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About QNRX
Quoin Pharmaceuticals, Ltd.
A specialty pharmaceutical company focused on rare and orphan diseases
Biological Technology
08/04/1986
07/29/2016
NASDAQ Stock Exchange
3
12-31
Depository Receipts (Ordinary Shares)
42127 Pleasant Forest Court, Ashburn, VA 20148-7349
--
Quoin Pharmaceuticals, Ltd., was established by the laws of the State of Israel on August 4, 1986. Between 1986 and 2013, the company underwent several name changes, most recently on August 28, 2013, when the company changed its current name from T.R.F. Capital Ltd. The Company is a clinical stage specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for the treatment of rare and orphan diseases. The company's initial focus is to develop products using proprietary own and licensed drug delivery technologies that may help address rare inherited skin diseases, especially those for which there are currently no approved treatments or cures.
Company Financials
EPS
QNRX has released its 2025 Q1 earnings. EPS was reported at -6.5, versus the expected -4.2, missing expectations. The chart below visualizes how QNRX has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
